NewGenIvf Group announces acquisition of cytometry tech, assets

NewGenIvf Group (NIVF) announced that it has acquired cytometry technology and assets including 18 fully-constructed cell-sorting and dispensing systems, eight partially constructed units, and six patents related to advanced microfluidic systems. This acquisition of physical machinery, intellectual property, and manufacturing know-how provides the Company with cutting-edge capabilities that will enhance its market position and support a planned U.S. expansion of its NewGenSort services. The acquisition builds upon NewGen’s strategic purchase earlier this year of MicroSort technology, which has been rebranded as NewGenSort. The 18 newly acquired cytometers will initially be deployed in the U.S. where permissible, a burgeoning market for fertility services